Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +8061.1% | +2483.2% | 1 / 3 | +11.9% | +0.56 pp | +0.51 pp | +2.0% | 0.79 | 67.04 | 1.619 | +11,9% | 8,1 | +8.061,1% | 67.04 | 72.39 | −7,4% |
| Pts | 12 | 12 | 4 | 4 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 8.000 (close price on 2026-10-08)EPS (TTM): 119,3
Financial charts
1.Revenue & growth
VND bn1.619Q3/26
1.Revenue & growth
VND bn1.619Q3/26
2.Profit & growth
VND bn8,07Q3/26
3.Profit mix (Penman)
VND bn6,06Q3/26
4.Margins & cost structure
%0.6%Q3/26
5.Returns & cash cycle
% · days4.5%Q3/26
6.Earnings quality & cash
VND bn12,9Q3/26
7.Asset structure
VND bn1.145Q3/26
8.Funding & debt health
VND bn · times1.145Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %67,0×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %159Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-306%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26